Filing Details
- Accession Number:
- 0000899243-17-008553
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-24 18:07:19
- Reporting Period:
- 2017-03-24
- Filing Date:
- 2017-03-24
- Accepted Time:
- 2017-03-24 18:07:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1662930 | Niraj Vasisht | C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Ave., Suite 225 Raleigh NC 27612 | Svp & Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-22 | 1,474 | $0.00 | 272,943 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2017-03-23 | 530 | $1.90 | 272,413 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2017-03-22 | 1,474 | $0.00 | 1,474 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-03-21 | 2017-03-22 | No | 4 | A | Direct |
Footnotes
- The shares of common stock reported on this Form 4 were acquired by the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's Long Term Incentive Plan.
- The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
Billionaire Hedge Funds
